Table 1 Demographic, dietary PUFA intake (presented as means and SDs) and fatty acid levels (presented as means of % fatty acid subtype from total plasma fatty acids) in the SCHS study
| Â | Â | SCHS cases | SCHS controls | p value |
|---|---|---|---|---|
N | Â | 717 | 644 | Â |
% Males | Â | 64.5 | 64.0 | Â |
Age | Â | 66.6 (7.80) | 66.2 (7.7) | Â |
Daily n-3 PUFA intake (g/day) | Â | 15.3 (7.6) | 15.1 (7.4) | Â |
Daily n-3 PUFA intake as proportion of total daily energy intake (%) | Â | 8.4 (2.2) | 8.3 (2.0) | Â |
Daily n-6 PUFA intake (g/day) | Â | 8.9 (4.8) | 9.1 (4.9) | Â |
Daily n-6 PUFA intake as proportion of total daily energy intake (%) | Â | 4.9 (1.8) | 5.1 (1.8) | Â |
Plasma n-3 PUFA subtypes | ||||
c183n3 (%) | Alphalinolenic acid (ALA) | 0.334 | 0.345 | 0.415 |
c205n3 (%) | Eicosapentaenoic acid (EPA) | 0.443 | 0.522 | <0.001 |
c226n3 (%) | Docosahexaenoic acid (DHA) | 2.263 | 2.459 | 0.009 |
Plasma n-6 PUFA subtypes | ||||
c182n6c (%) | Linoleic acid (LA) | 36.137 | 36.440 | 0.232 |
c183n6 (%) | Gammalinolenic acid (GLA) | 0.232 | 0.223 | 0.237 |
c203n6 (%) | Dihomogammalinolenic acid (DGLA) | 0.932 | 0.918 | 0.460 |
c204n6 (%) | Arachidonic acid (AA) | 7.561 | 7.658 | 0.307 |